Urine Glucose Testing Research Articles

Clinical Evaluation of Metabolic Control in Diabetes

This review examines the current status of the clinical evaluation of diabetic control. The assessment of the patient's symptoms and signs is important but requires laboratory confirmation. Major metabolic derangements usually occur before their clinical detection is feasible. To be complete, the laboratory assessment of diabetic control should include the insulin concentration in blood or urine. At present insulin and other hormones assays have played mainly an investigative role. Glucose measurements in blood and urine continue to be the standards for evaluation of diabetic control. Glucose tolerance tests or carefully timed preprandial and postprandial plasma glucose measurements on several successive days under consistent conditions of diet and exercise provide data for adequate evaluation of diabetic control. The addition of urinary glucose monitoring to the blood sampling makes the evaluation more complete. Glucose variability measurements in blood and/or urine provide useful data for characterizing patients, for comparing them with other diabetics, with nondiabetic normals, and with themselves from time to time. Despite their limitations, urine glucose tests are valuable and worth evaluating so as to provide for each patient the most appropriate method of testing. Methods are described for screening patients for atypical blood-to-urine glucose relationships (“renal glucose threshold”) and for estimating such thresholds. Among lipid metabolic indices of insulin deficiency the urinary ketone bodies are the most commonly measured in clinical medicine. Triglycerides and cholesterol elevations may in part reflect disturbed diabetic control and may warrant a trial of intensified antidiabetic therapy. The protein metabolic changes of diabetes during hyperglycemia are measurable as decreased levels of plasma alanine and increased levels of branched-chain amino acids. By sensitive quantitative methods, albuminuria is also demonstrably increased during impaired diabetic control. Improved diabetic regulation restores these protein abnormalities toward normal. These newer refinements for evaluating diabetic control await clinical application. Glycosylation of hemoglobin, identifiable by an increased proportion as hemoglobin A1c, is of special interest as a longer-term indicator of hyperglycemia. As clinical interest in more complete normalization of diabetic metabolic changes is intensifying, a wider array of methods are becoming available for determining the degree to which metabolic control is normalized.

Performance of Technical Skills of Diabetes Management: Increased Independence After a Camp Experience

This study examines some educational effects of a camp experience on independent performance of tasks in the management of diabetes mellitus. One hundred and eleven children were studied with regard to insulin administration, urine glucose testing, recognition of hypoglycemic reactions, adherence to diet, and over-all independence. There was a significant increase in independent measurement of insulin dose, administration of insulin injections, and urine glucose testing. No significant differences were seen in dietary adherence of ability to recognize hypoglycemic reactions. Precamp data indicated that returning campers demonstrated greater independence in insulin administration prior to camp than did new campers. After camp, both new and returning campers showed significant increases in independent performance of dose measurement and injection. It is concluded that a camp educational experience contributes to both the knowledge and performance of self-care techniques required in the management of diabetes mellitus.

Urine Glucose Tests for Diabetic Patients with Impaired Vision

A colorimetric test procedure called Mega-Diastix is described for detection and measurement of glucose in urine. The test is designed for use by diabetic patients with imparied vision. Data establishing the performance capabilities of this rapid, convenient test are presented. As an internal standard, the recommended procedure utilizes effervescent control tablets for preparation of simulated urine. Also described is a touch fermentation test for detection of urinary glucose by totally blind patients. Data are given that demonstrate the accuracy and ease of performance of this test, which entails a rapid yeast fermentation. An internal standard is also incorporated into the procedure for this test.

False Positive Urine Glucose Test in Two Patients Receiving Trioxazine

The Journal of New DrugsVolume 6, Issue 3 p. 153-154 False Positive Urine Glucose Test in Two Patients Receiving Trioxazine JAMES L. CLAGHORN M.D., JAMES L. CLAGHORN M.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this authorJOHN KINROSS-WRIGHT M.D., JOHN KINROSS-WRIGHT M.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this authorWILLIAM M. McISAAC M.D., Ph.D., WILLIAM M. McISAAC M.D., Ph.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this author JAMES L. CLAGHORN M.D., JAMES L. CLAGHORN M.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this authorJOHN KINROSS-WRIGHT M.D., JOHN KINROSS-WRIGHT M.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this authorWILLIAM M. McISAAC M.D., Ph.D., WILLIAM M. McISAAC M.D., Ph.D. Houston, Tex. Dr. Claghorn is Chief, Clinical Research Section and Instructor in Psychiatry; Dr.Kinross-Wright is Director, and Professor of Psychiatry; Dr. Mcisaac is Head, Division of Biological Research and Associate Professor of Biochemistry and Psychiatry. From the Houston State Psychiatric Institute and the Department of Psychiatry, Baylor University College of Medicine, respectively, Houston, Texas. This research supported in part by National Institutes of Health Grant MH-08399.Search for more papers by this author First published: May‐June 1966 https://doi.org/10.1177/009127006600600305Citations: 1 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume6, Issue3May‐June 1966Pages 153-154 RelatedInformation

The determination of the time of ovulation.

Literature on the various tests for detecting ovulation is reviewed. The tests discussed include: direct methods (flushing of ova from the tubes) recording of basal body temperature the benzidine test for uterine bleeding the Kraus method cervical mucus tests (fern test and spinnbarkeit) cold pressor test conjunctiva test measurement of electric potentials endometrial biopsy determination of plasma and urinary estrogens the hypermic response of the immature rat ovary to morning urine (Farris test) glucose test glucoseamine test determination of urinary gonadotropins determination of hydrogen ion concentrations in vaginal secretions pregnanediol determinations determination of the reduction time of oxyhemoglobin in the blood (Samuels test) mittleschmerz Takata test urinary sedimentation test analysis of vaginal smears and the Vitamin-C test (Pillay test). Since there is no good reliable single test it is suggested that a combination of several tests would afford a better estimation of when ovulation occurs.

Urine glucose testing by glucose oxidase methods; a critical evaluation.

Urine glucose testing by glucose oxidase methods; a critical evaluation.